Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED BALANCE SHEETS

v3.8.0.1
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
Mar. 31, 2018
Dec. 31, 2017
CURRENT ASSETS:    
Cash and cash equivalents $ 56,678,000 $ 51,101,000
Other investments 12,790,000 3,054,000
Royalty receivables, net 424,000 575,000
Prepaid taxes 125,000
Other current assets 61,000 83,000
Total Current Assets 69,953,000 54,938,000
OTHER ASSETS:    
Deferred tax assets 168,000 168,000
Patent, net of accumulated amortization 2,126,000 2,169,000
Security deposits 19,000 19,000
Total Other Assets 2,313,000 2,356,000
TOTAL ASSETS 72,266,000 57,294,000
CURRENT LIABILITIES:    
Accounts payable 429,000 244,000
Income taxes payable 2,319,000
Accrued contingency fees and related costs 7,641,000 1,780,000
Accrued payroll 85,000 709,000
Other accrued expenses 174,000 149,000
TOTAL LIABILITIES 10,648,000 2,882,000
COMMITMENTS AND CONTINGENCIES
STOCKHOLDERS' EQUITY    
Preferred stock, $0.01 par value, authorized 10,000,000 shares; none issued and outstanding at March 31, 2018 December 31, 2017
Common stock, $0.01 par value; authorized 50,000,000 shares; 23,753,062 and 23,843,915 shares issued and outstanding at March 31, 2018 and December 31, 2017, respectively 238,000 238,000
Additional paid-in capital 64,690,000 64,435,000
Accumulated deficit (3,243,000) (10,219,000)
Accumulated other comprehensive loss (67,000) (42,000)
TOTAL STOCKHOLDERS' EQUITY 61,618,000 54,412,000
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 72,266,000 $ 57,294,000